These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

998 related articles for article (PubMed ID: 11463130)

  • 41. The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor.
    Samuels BA; Nautiyal KM; Kruegel AC; Levinstein MR; Magalong VM; Gassaway MM; Grinnell SG; Han J; Ansonoff MA; Pintar JE; Javitch JA; Sames D; Hen R
    Neuropsychopharmacology; 2017 Sep; 42(10):2052-2063. PubMed ID: 28303899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A case of tianeptine abuse].
    Saatçioğlu O; Erim R; Cakmak D
    Turk Psikiyatri Derg; 2006; 17(1):72-5. PubMed ID: 16528638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled study.
    Sohn W; Lee OY; Kwon JG; Park KS; Lim YJ; Kim TH; Jung SW; Kim JI
    Neurogastroenterol Motil; 2012 Sep; 24(9):860-e398. PubMed ID: 22679908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurobiological and clinical effects of the antidepressant tianeptine.
    Kasper S; McEwen BS
    CNS Drugs; 2008; 22(1):15-26. PubMed ID: 18072812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of the antidepressant drug tianeptine on plasma and platelet serotonin of depressive patients and healthy controls.
    Ortiz J; Mariscot C; Alvarez E; Artigas F
    J Affect Disord; 1993 Dec; 29(4):227-34. PubMed ID: 7510316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Placebo-controlled study of tianeptine in major depressive episodes.
    Costa e Silva JA; Ruschel SI; Caetano D; Rocha FL; da Silva Lippi JR; Arruda S; Ozun M
    Neuropsychobiology; 1997; 35(1):24-9. PubMed ID: 9018020
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
    Gunasekara NS; Noble S; Benfield P
    Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Tolerability of tianeptine in 170 patients with depression treated during one year].
    Lôo H; Ganry H; Marey C; Briole G; Castelnau D; Charbonnier JF; Dachary JM; Danion JM; Darcourt G; Capdeville C
    Encephale; 1990; 16(6):445-52. PubMed ID: 2101783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
    Grimsley SR; Jann MW
    Clin Pharm; 1992 Nov; 11(11):930-57. PubMed ID: 1464219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.
    Davis R; Whittington R; Bryson HM
    Drugs; 1997 Apr; 53(4):608-36. PubMed ID: 9098663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine.
    McEwen BS; Olié JP
    Mol Psychiatry; 2005 Jun; 10(6):525-37. PubMed ID: 15753957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term administration of tianeptine in depressed patients after alcohol withdrawal.
    Malka R; Lôo H; Ganry H; Souche A; Marey C; Kamoun A
    Br J Psychiatry Suppl; 1992 Feb; (15):66-71. PubMed ID: 1389025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent pharmacologic advances in antidepressant therapy for the elderly.
    Preskorn SH
    Am J Med; 1993 May; 94(5A):2S-12S. PubMed ID: 8503477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Does addiction to antidepressants exist? About a case of one addiction to tianeptine].
    Guillem E; Lépine JP
    Encephale; 2003; 29(5):456-9. PubMed ID: 14615695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of major depression and anxiety with the selective serotonin re-uptake enhancer tianeptine in the outpatient psychiatric care setting of India.
    Sonawalla S; Chakraborty N; Parikh R
    J Indian Med Assoc; 2003 Feb; 101(2):116-7, 124. PubMed ID: 12841497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment with tianeptine of depressive disorders in drug addicts under withdrawal. Assessment of efficacy and study of dependence].
    Lôo H; Hantzberg P; Defrance R; Kamoun A; Deniker P
    Encephale; 1987; 13(5):295-9. PubMed ID: 3322802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders].
    Cvjetković-Bosnjak M; Knezević A; Soldatović-Stajić B
    Med Pregl; 1999; 52(3-5):108-11. PubMed ID: 10518394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical pharmacology and use of paroxetine, a new selective serotonin reuptake inhibitor.
    Nemeroff CB
    Pharmacotherapy; 1994; 14(2):127-38. PubMed ID: 8197030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tianeptine and alcohol dependence.
    Favre JD; Guelfi-Sozzi C; Delalleau B; Lôo H
    Eur Neuropsychopharmacol; 1997 Oct; 7 Suppl 3():S347-51. PubMed ID: 9405962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.